Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth

Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial ...
Finanznachrichten

MustGrow Biologics Corp.: MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

Bayer's commercial license covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa. MustGrow to receive upfront license fees and milestone ...
MobiHealthNews

Bayer leads OneDrop's $40M Series B, companies ink commercial licensing agreement

Digital diabetes and chronic care company OneDrop has landed $40 million in a Series B funding round led by pharma giant Bayer. This news coincides with the announcement that Bayer inked a deal with ...
GEN

Bayer Returns Commercial Rights Covering Human Thrombin Therapy to ZymoGenetics

Bayer will retain the Canadian license, while ZymoGenetics will look for partners in ex-U.S. territories. ZymoGenetics is regaining global promotion rights, except Canada, for Recothrom Thrombin, ...
Business Line

Bayer starts commercial use of drone services in Indian agri sector

https://www.thehindubusinessline.com/economy/agri-business/bayer-starts-commercial-use-of-drone-services-in-indian-agri-sector/article66000708.ece Copy Bayer said, on ...
Yahoo Finance

MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce ...